Portal de Periódicos da CAPES

Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells

2021; Springer Nature; Volume: 40; Issue: 36 Linguagem: Inglês

10.1038/s41388-021-01945-9

1476-5594

Mitsuro Kanda, Dai Shimizu, Shunsuke Nakamura, Koichi Sawaki, Shinichi Umeda, Takashi Miwa, Haruyoshi Tanaka, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Chie Tanaka, Goro Nakayama, Yohei Iguchi, Masahisa Katsuno, Yasuhiro Kodera,

PI3K/AKT/mTOR signaling in cancer